Summit Therapeutics, Inc. (SMMT)
21.47
+0.64
(+3.07%)
USD |
NASDAQ |
Apr 30, 16:00
17.88
-3.59
(-16.72%)
After-Hours: 19:02
Summit Therapeutics Total Liabilities (Quarterly) : 92.32M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 777.09M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Eli Lilly & Co. | 85.94B |
| Merck & Co., Inc. | 84.20B |
| Soleno Therapeutics, Inc. | 113.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 751.18M |
| Shareholders Equity (Quarterly) | 658.86M |
| Debt to Equity Ratio | 0.0317 |
| Current Ratio | 9.869 |
| Net Debt Paydown Yield | 0.02% |